AI Verdict
GILD has stronger fundamentals based on our AI analysis.
GILD vs MRK Fundamental Comparison
| Metric | GILD | MRK |
|---|---|---|
| Revenue | $29.4B | $65.0B |
| Net Income | $8.5B | $18.3B |
| Net Margin | 28.9% | 28.1% |
| ROE | 37.5% | 34.7% |
| ROA | 14.4% | 13.3% |
| Current Ratio | 1.55x | 1.54x |
| Debt/Equity | 1.10x | 0.89x |
| EPS | $6.78 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GILD vs MRK: Frequently Asked Questions
Is GILD or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. GILD is rated BUY (82% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does GILD compare to MRK fundamentally?
GILEAD SCIENCES, INC. has ROE of 37.5% vs Merck & Co., Inc.'s 34.7%. Net margins are 28.9% vs 28.1% respectively.
Which stock pays higher dividends, GILD or MRK?
GILD has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GILD or MRK for long term?
For long-term investing, consider that GILD has BUY rating with 82% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GILD vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs MRK, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.